肺炎新诊断检测方法：在临床实践中有何作用？
New diagnostic tests for pneumonia: what is their role in clinical practice?
机构信息
Infectious Disease Section, Internal Medicine Department, Northeastern Ohio Universities College of Medicine and Pharmacy, Rootstown, OH 44272, USA.
出版信息
Clin Chest Med. 2011 Sep;32(3):417-30. doi: 10.1016/j.ccm.2011.05.011. Epub 2011 Jul 12.
Abstract
The utility of diagnostic studies to determine the etiologic agents of community-acquired pneumonia has been controversial in part because of the lack of rapid, accurate, easily performed, and cost-effective methods. Advancements in molecular testing methods and biological markers are becoming available with marked expansion of diagnostic capability for infectious diseases. Subsequent studies and clinical experience will clarify their real clinical value.
摘要
诊断研究在确定社区获得性肺炎的病因方面的实用性一直存在争议，部分原因是缺乏快速、准确、易于操作且具有成本效益的方法。随着传染病诊断能力的显著扩展，分子检测方法和生物标志物的进步正在成为可能。随后的研究和临床经验将阐明它们的真正临床价值。
相似文献
1
New diagnostic tests for pneumonia: what is their role in clinical practice?
Clin Chest Med. 2011 Sep;32(3):417-30. doi: 10.1016/j.ccm.2011.05.011. Epub 2011 Jul 12.
2
The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia.
Diagn Microbiol Infect Dis. 2015 Dec;83(4):400-6. doi: 10.1016/j.diagmicrobio.2015.08.001. Epub 2015 Aug 5.
3
The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
J Infect Chemother. 2014 Oct;20(10):616-20. doi: 10.1016/j.jiac.2014.06.003. Epub 2014 Jul 11.
4
Impact of microbial Aetiology on mortality in severe community-acquired pneumonia.
BMC Infect Dis. 2018 Sep 4;18(1):451. doi: 10.1186/s12879-018-3366-4.
5
Procalcitonin is useful in identifying bacteraemia among children with pneumonia.
Scand J Infect Dis. 2010 Sep;42(9):644-9. doi: 10.3109/00365541003796775.
6
Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.
Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3397-405. doi: 10.1007/s10096-012-1708-5. Epub 2012 Aug 5.
7
Procalcitonin in children admitted to hospital with community acquired pneumonia.
Arch Dis Child. 2001 Apr;84(4):332-6. doi: 10.1136/adc.84.4.332.
8
Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.
Clin Infect Dis. 2000 Aug;31(2):347-82. doi: 10.1086/313954. Epub 2000 Sep 7.
9
The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia.
Diagn Microbiol Infect Dis. 2016 Sep;86(1):102-7. doi: 10.1016/j.diagmicrobio.2016.06.008. Epub 2016 Jun 15.
10
Point-of-care testing for community-acquired pneumonia.
Lancet Infect Dis. 2013 Aug;13(8):647-9. doi: 10.1016/S1473-3099(13)70165-8.
引用本文的文献
1
Diagnostic and Prognostic Roles of Procalcitonin and Other Tools in Community-Acquired Pneumonia: A Narrative Review.
Diagnostics (Basel). 2023 May 26;13(11):1869. doi: 10.3390/diagnostics13111869.
2
Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group.
Respir Res. 2022 Sep 10;23(1):239. doi: 10.1186/s12931-022-02117-3.
3
The extent of microbiological testing is associated with alteration of antibiotic therapy in adults with community-acquired pneumonia.
Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1359-1366. doi: 10.1007/s10096-019-03561-8. Epub 2019 Apr 25.
4
Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway.
BMC Infect Dis. 2015 Feb 15;15:64. doi: 10.1186/s12879-015-0803-5.
5
Health promotion, risk stratification, and treatment options to decrease hospitalization rates for community-acquired pneumonia in adults.
J Am Assoc Nurse Pract. 2014 Oct;26(10):537-49. doi: 10.1002/2327-6924.12072. Epub 2013 Sep 3.
6
What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?
Infect Dis Clin North Am. 2013 Mar;27(1):157-75. doi: 10.1016/j.idc.2012.11.007. Epub 2012 Dec 12.
7
What is the role of newer molecular tests in the management of CAP?
Infect Dis Clin North Am. 2013 Mar;27(1):49-69. doi: 10.1016/j.idc.2012.11.012.
本文引用的文献
1
Viral community-acquired pneumonia: if we do not diagnose it and do not treat it, can it still hurt us?
Chest. 2010 Oct;138(4):767-9. doi: 10.1378/chest.10-0820.
2
A 29-year-old woman with flu-like symptoms: review of influenza diagnosis and treatment.
JAMA. 2010 Aug 11;304(6):671-8. doi: 10.1001/jama.304.6.671.
3
Emerging advances in rapid diagnostics of respiratory infections.
Infect Dis Clin North Am. 2010 Sep;24(3):791-807. doi: 10.1016/j.idc.2010.04.006.
4
Limited utility of culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae for diagnosis of respiratory tract infections.
J Clin Microbiol. 2010 Sep;48(9):3380-2. doi: 10.1128/JCM.00321-10. Epub 2010 Jul 7.
5
Prognostic value of procalcitonin in community-acquired pneumonia.
Eur Respir J. 2011 Feb;37(2):384-92. doi: 10.1183/09031936.00035610. Epub 2010 Jul 1.
6
Development of triplex SYBR green real-time PCR for detecting Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella spp. without extraction of DNA.
Jpn J Infect Dis. 2010 May;63(3):173-80.
7
Procalcitonin for guidance of antibiotic therapy.
Expert Rev Anti Infect Ther. 2010 May;8(5):575-87. doi: 10.1586/eri.10.25.
8
Respiratory viruses in adults with community-acquired pneumonia.
Chest. 2010 Oct;138(4):811-6. doi: 10.1378/chest.09-2717. Epub 2010 Apr 2.
9
Performance measure of urinary antigen in patients with Streptococcus pneumoniae bacteremia.
Diagn Microbiol Infect Dis. 2010 Jun;67(2):129-33. doi: 10.1016/j.diagmicrobio.2010.01.005. Epub 2010 Mar 24.
10
Does sputum culture affect the management and/or outcome of community-acquired pneumonia?
East Mediterr Health J. 2009 Jul-Aug;15(4):792-9.
Zotero 插件